{"result": "(\"entity\"<|>GLUTAMINE<|>ORGANIZATION<|>Glutamine is an amino acid that is often used in nutritional support for patients, particularly in the context of cancer management and bone marrow transplantation.)\n##\n(\"entity\"<|>CANCER<|>EVENT<|>Cancer is a disease characterized by uncontrolled cell growth and can require various treatments, including bone marrow transplantation.)\n##\n(\"entity\"<|>CHEMOTHERAPY<|>EVENT<|>Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells, often leading to nutritional challenges for patients.)\n##\n(\"entity\"<|>NUTRITIONAL ISSUES IN CANCER MANAGEMENT<|>EVENT<|>This refers to the various dietary and nutritional challenges faced by patients undergoing treatment for cancer.)\n##\n(\"entity\"<|>BLOOD<|>ORGANIZATION<|>Blood is a vital fluid in the body that can be affected by various medical treatments, including bone marrow transplantation.)\n##\n(\"entity\"<|>HEMATOLOGICAL MALIGNANCY<|>EVENT<|>Hematological malignancies are cancers that affect blood, bone marrow, and lymph nodes, often treated with bone marrow transplantation.)\n##\n(\"entity\"<|>GRAFT VERSUS HOST DISEASE<|>EVENT<|>Graft versus host disease is a complication that can occur after a bone marrow transplant, where the donated cells attack the recipient's body.)\n##\n(\"entity\"<|>TOTAL PARENTERAL NUTRITION<|>ORGANIZATION<|>Total parenteral nutrition is a method of feeding that bypasses the gastrointestinal tract, often used for patients unable to eat normally.)\n##\n(\"entity\"<|>ENERGY EXPENDITURE<|>EVENT<|>Energy expenditure refers to the amount of energy a person uses, which can be affected by medical treatments like bone marrow transplantation.)\n##\n(\"entity\"<|>NOSOCOMIAL INFECTION<|>EVENT<|>Nosocomial infections are infections acquired in a hospital setting, which can be a significant risk for patients undergoing treatments like transplants.)\n##\n(\"relationship\"<|>GLUTAMINE<|>CANCER<|>Glutamine is often used in the nutritional management of cancer patients to support their treatment and recovery<|>7)\n##\n(\"relationship\"<|>CHEMOTHERAPY<|>NUTRITIONAL ISSUES IN CANCER MANAGEMENT<|>Chemotherapy can lead to various nutritional issues that need to be addressed for effective patient management<|>8)\n##\n(\"relationship\"<|>BLOOD<|>HEMATOLOGICAL MALIGNANCY<|>Blood is directly affected by hematological malignancies, which can lead to the need for treatments like bone marrow transplantation<|>9)\n##\n(\"relationship\"<|>GRAFT VERSUS HOST DISEASE<|>BONE MARROW TRANSPLANTATION<|>Graft versus host disease is a potential complication that arises specifically from bone marrow transplantation<|>10)\n##\n(\"relationship\"<|>TOTAL PARENTERAL NUTRITION<|>BONE MARROW TRANSPLANTATION<|>Total parenteral nutrition is often necessary for patients undergoing bone marrow transplantation who cannot eat normally<|>8)\n##\n(\"relationship\"<|>ENERGY EXPENDITURE<|>BONE MARROW TRANSPLANTATION<|>Energy expenditure is an important consideration in the care of patients undergoing bone marrow transplantation<|>6)\n##\n(\"relationship\"<|>NOSOCOMIAL INFECTION<|>BONE MARROW TRANSPLANTATION<|>Patients undergoing bone marrow transplantation are at increased risk for nosocomial infections due to their compromised immune systems<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: el uso de glutamina ni de fórmulas inmunomoduladoras en el soporte nutricional de estos pacientes, en espera de ensayos clínicos de mayor tamaño y adecuado diseño que despejen las controversias existentes.\n\n## 10. Bibliografía\n\n1. Bociek RG, Stewart DA, Armitage JO. Bone marrow transplantation-current-concepts. J Invest Med 1995; 43:127-35.\n2. Laviano A, Meguid MM. Nutritional issues in cancer management. Nutrition 1996; 12:358-371.\n3. Schulte C, Reinhardt W, Beelen D, Mann K, Schaefer U. Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Trasplant 1998; 22:1171-1178.\n4. Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barriers injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000; 25:1269-1278.\n5. Ferrara JLM, DEG HJ. Graft versus host disease. N Engl J Med 1991; 324:667-674.\n6. Bearman SI. The syndrome of hepatic veno-occlusive disease after transplantation. Blood 1995; 85:305-320.\n7. Rouse K, Nwokendi E, Woodliff E, Epstein J, Klimberg VS. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg 1995; 221:420-426.\n8. Cheney CL, Abson KG, Aker SN et al. Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer 1987; 59:1515-1519.\n9. Herrmann VM, Petruska PJ. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract 1993; 8:19-27.\n10. Smedmyr B, Wibeu L, Simonsson B, Oberg G. Impaired glucose tolerance after autologous bone marrow transplantation. Bone Marrow Transplant 1990; 6:89-92.\n11. Nemanaitis J, Deeg HJ, Yee GL. High ciclosporine concentration after bone marrow transplantation associated with hypertriglyceridaemia. Lancet 1986; 2:744-745.\n12. Clemens MR, Landner C, Ehninger G et al. Plasma vitamin E and beta carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am J Clin Nutr 1990; 51:216-219.\n13. Antila HM, Salo MS, Kirvela O, Nanto V, Rajamaki A, Toivanen A. Serum trace element concentrations and iron metabolism in allogenic bone marrow transplant recipients. Ann Med 1992; 24:55-59.\n14. Hutchinson ML, Clemans GW, Springmeyer SC, Flournoy N. Energy expenditure estimation in recipients of marrow transplants. Cancer 1984; 54:1734-1738.\n15. Chamouard Cogoluenhes V, Chambrier C, Michallet M et al. Energy expenditure during allogenic and autologous marrow transplantations. Clin Nutr 1998; 17:253-257.\n16. Elwyn DH. Nutritional requirements of adult surgical patients. Crit Care Med 1980; 8:9-20.\n17. Shikora SA, Jensen GL. Hypoenergetic nutrition support in hospitalized obese patients. Am J Clin Nutr 1997; 66:679-680.\n18. Choban PS, Heckler R, Burge JC, Flancbaum L. Increased incidence of nosocomial infection in obese surgical patients. Am Surg 1995; 61:1001-1005.\n19. Choban PS, Weireter LJ Jr, Maynes C. Obesity and increased mortality in blunt trauma. J Trauma 1991; 31:1253-1257.\n20. Muscaritoli M, Conversano L, Torrelli GF et al. Clinical and metabolic effect of different parenteral nutrition regimens in patients undergoing allogenic bone marrow transplantation. Trasplantation 1998; 66:610-616.\n21. van Dalen EC, Mank A, Leclercq E, Mulder RL, Davies M, Kersten MJ, et al. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. Cochrane Database Syst Rev 2016 Apr 24;4:CD006247.\n22. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al., Center for International Blood and Marrow Research, National Marrow Donor program, European Blood and MarrowTransplant Group, American Society of Blood and Marrow Transplantation, Canadian Blood and Marrow Transplant Group, Infectious Diseases Society of America, Society for healthcare Epidemiology of America, Association of Medical microbiology and Infectious Disease Canada, Centers for Disease Control and Prevention. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl 2009;15:1143e238.\n23. Goldman JM, Schmitz N, Niethammer D, Gratwohl A. Allogenic and aut\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>BONE MARROW TRANSPLANTATION<|>EVENT<|>Bone marrow transplantation is a medical procedure that involves the transplantation of stem cells to treat various diseases, including hematological malignancies.)\n##\n(\"entity\"<|>NUTRITION<|>ORGANIZATION<|>Nutrition is a field of study and practice focused on the dietary needs and health of patients, particularly in the context of medical treatments like bone marrow transplantation.)\n##\n(\"entity\"<|>CENTER FOR INTERNATIONAL BLOOD AND MARROW RESEARCH<|>ORGANIZATION<|>This organization conducts research and provides guidelines for blood and marrow transplantation practices globally.)\n##\n(\"entity\"<|>NATIONAL MARROW DONOR PROGRAM<|>ORGANIZATION<|>A program that facilitates the donation of bone marrow and stem cells to patients in need of transplants.)\n##\n(\"entity\"<|>EUROPEAN BLOOD AND MARROW TRANSPLANT GROUP<|>ORGANIZATION<|>A group that collaborates on research and guidelines for blood and marrow transplantation in Europe.)\n##\n(\"entity\"<|>AMERICAN SOCIETY OF BLOOD AND MARROW TRANSPLANTATION<|>ORGANIZATION<|>A professional organization that focuses on the advancement of blood and marrow transplantation practices in the United States.)\n##\n(\"entity\"<|>CANADIAN BLOOD AND MARROW TRANSPLANT GROUP<|>ORGANIZATION<|>A group that promotes research and best practices in blood and marrow transplantation in Canada.)\n##\n(\"entity\"<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>ORGANIZATION<|>A professional society that focuses on the study and treatment of infectious diseases, including those that may affect transplant patients.)\n##\n(\"entity\"<|>SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF AMERICA<|>ORGANIZATION<|>An organization dedicated to the prevention of healthcare-associated infections and improving patient safety.)\n##\n(\"entity\"<|>ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA<|>ORGANIZATION<|>A Canadian organization that focuses on the study and treatment of infectious diseases and microbiology.)\n##\n(\"relationship\"<|>CENTER FOR INTERNATIONAL BLOOD AND MARROW RESEARCH<|>NATIONAL MARROW DONOR PROGRAM<|>Both organizations work together to improve practices and outcomes in blood and marrow transplantation<|>7)\n##\n(\"relationship\"<|>EUROPEAN BLOOD AND MARROW TRANSPLANT GROUP<|>AMERICAN SOCIETY OF BLOOD AND MARROW TRANSPLANTATION<|>These organizations collaborate on international guidelines and research for blood and marrow transplantation<|>6)\n##\n(\"relationship\"<|>CANADIAN BLOOD AND MARROW TRANSPLANT GROUP<|>CENTER FOR INTERNATIONAL BLOOD AND MARROW RESEARCH<|>The Canadian group collaborates with the center to enhance transplantation practices in Canada<|>5)\n##\n(\"relationship\"<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>SOCIETY FOR HEALTHCARE EPIDEMIOLOGY OF AMERICA<|>Both societies focus on preventing infections in healthcare settings, particularly for vulnerable populations like transplant patients<|>8)\n##\n(\"relationship\"<|>ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA<|>INFECTIOUS DISEASES SOCIETY OF AMERICA<|>Both organizations aim to improve the understanding and treatment of infectious diseases, especially in the context of medical procedures like transplants<|>6)\n<|COMPLETE|>"}]}